• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INTELLANAV STABLEPOINT OPEN-IRRIGATED; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INTELLANAV STABLEPOINT OPEN-IRRIGATED; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Model Number M004ERFSDS96200
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Pericarditis (4448)
Event Date 03/01/2022
Event Type  Injury  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
(b)(4) clinical study, subject id: (b)(6).Index ablation procedure was performed on (b)(6) 2022, with an intellanav stablepoint open-irrigated catheter.It was reported that the patient experienced pericarditis one day post procedure.The event is ongoing.No additional information has been reported.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.
 
Event Description
Newton af clinical study, subject id: (b)(6).Index ablation procedure was performed on march 01 2022, with an intellanav stablepoint open-irrigated catheter.It was reported that the patient experienced pericarditis one day post procedure.The event is ongoing.Additional information received indicated that the patient presented with light chest pain post ablation and the suspected cause was the index ablation procedure.Naproxen and colchicine were administered.
 
Event Description
Newton af clinical study, subject id: (b)(6).Index ablation procedure was performed on march 01 2022, with an intellanav stablepoint open-irrigated catheter.It was reported that the patient presented with light chest pain and pericarditis post ablation post procedure.The suspected cause was the index ablation procedure.Naproxen and colchicine were administered.The event is ongoing.Additional information received indicated the date of event was march 01 2022.
 
Manufacturer Narrative
Additional information was added to b3, b5.It was indicated that the device will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.
 
Event Description
Newton af clinical study (b)(4).Index ablation procedure was performed on (b)(6) 2022, with an intellanav stablepoint open-irrigated catheter.It was reported that the patient experienced light chest pain pericarditis post procedure.The suspected cause was the ablation procedure.Naproxen and colchicine was adjusted.It was further reported that the event was resolved on (b)(6) 2022.A repeat ablation procedure was also performed on (b)(6) 2022.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTELLANAV STABLEPOINT OPEN-IRRIGATED
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
302 parkway, global park
la aurora - heredia
CS  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key13771437
MDR Text Key287246728
Report Number2134265-2022-02943
Device Sequence Number1
Product Code OAE
Combination Product (y/n)N
Reporter Country CodeCA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 03/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/10/2023
Device Model NumberM004ERFSDS96200
Device Lot Number0026788899
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/07/2022
Initial Date FDA Received03/15/2022
Supplement Dates Manufacturer Received03/19/2022
05/13/2022
02/17/2023
Supplement Dates FDA Received04/14/2022
06/01/2022
03/15/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/10/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age65 YR
Patient SexFemale
Patient Weight93 KG
-
-